Metabolomics and exploratory mendelian randomization identify indole-3-propionic acid associated with

Jingyi Duan1, Xue Li1, Fei Li1

  • 1Department of Pharmacy, Laboratory of Hepato-Intestinal Diseases and Metabolism, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Insights

Doxorubicin (DOX) causes testicular damage by increasing oxidative stress. Indole-3-propionic acid (IPA) shows potential in protecting against this injury and may reduce male infertility risk.

Area of Science:

  • Metabolomics
  • Toxicology
  • Reproductive Biology

Background:

  • Doxorubicin (DOX) chemotherapy causes severe testicular toxicity, limiting its use.
  • Oxidative stress and apoptosis in testes are key mechanisms of DOX-induced injury.
  • Metabolic microenvironment alterations may influence testicular response to DOX, but this is poorly understood.

Purpose of the Study:

  • To investigate metabolic profile changes in testes and plasma following DOX administration.
  • To identify key metabolites associated with DOX-induced testicular injury and male infertility risk.
  • To validate the protective role of candidate metabolites in cellular models.

Main Methods:

  • Metabolomic profiling of mouse testes and plasma after DOX treatment.
  • Mendelian randomization (MR) analysis using human cohorts to link metabolites with male infertility.
  • In vitro validation of identified metabolites in TM4 cells exposed to DOX.

Main Results:

  • Significant alterations in 76 testicular and 48 plasma metabolites were observed, with 24 common changes.
  • Exploratory MR analysis suggested indole-3-propionic acid (IPA) is inversely associated with male infertility risk.
  • IPA mitigated DOX-induced reactive oxygen species and modulated the NRF2/HO-1 pathway in TM4 cells.

Conclusions:

  • DOX-induced testicular injury is characterized by widespread metabolic disturbances.
  • IPA emerges as a promising candidate metabolite for ameliorating DOX testicular toxicity.
  • Further research into IPA's therapeutic potential for male infertility is warranted.